Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
Clinical trial NCT06975787 · RECRUITING
Trial details
- NCT number
- NCT06975787
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-22
- Primary completion
- 2029-09-10
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.